Events by this organizer

Are you a cancer researcher or bioinformatician wanting to learn more about how the experts at NCI’s Genomic Data Commons (GDC) process a variety of molecular data types? This month’s GDC support webinar is for you!

University of Chicago’s Dr. Zhenyu Zhang and Dr. Bill Wysocki will describe the bioinformatics pipelines for a medley of data types. Users can even learn about information stored in surprising places!

During the webinar, the GDC bioinformatics team will:

• provide an overview of whole genome sequencing (WGS), methylation, copy number, protein expression (RPPA), and other data types available at the GDC and how they are processed.
• describe the GDC’s WGS mutation and copy number variant calling pipelines.
• demonstrate how to locate and download these data types from the GDC.

As part of the NCI Cancer Research Data Commons (CRDC), the GDC provides the cancer research community with data and tools to access, analyze, and share valuable genomic data.

Presenters:

• Zhenyu Zhang, Ph.D.

Dr. Zhang is the GDC co-principal investigator at the University of Chicago.

• Bill Wysocki, Ph.D.

Dr. Wysocki is the director of User Services and Outreach for the GDC at the University of Chicago.

Join the upcoming NCI Containers and Workflows Interest Group (CWIG) webinar to learn about the research and functionality available through the University of California, San Francisco’s (UCSF) Information Commons.

As an open-source platform, the commons support deep data science and artificial intelligence methodologies. The platform offers access to de-identified clinical, imaging, and genomic profile data for 5.5 million UCSF patients. Drs. Sharat Israni and Gundolf Schenk will highlight examples of how leveraging this multidimensional data can result in richer scientific findings for cancer research.

At the next CWIG webinar in September, a practicing oncologist will present how they use this research data platform to conduct cancer research.

CWIG is a monthly webinar series that brings together data scientists, bioinformaticians, computer scientists, and researchers to learn more about cloud computing and container technologies, workflows, and pipelines that could drive cancer data science.

The webinar series features a variety of presenters from across NIH, industry, and academia. Though cancer research is the focus of the series, unrelated data science and cloud computing topics are still welcome. In the last year, the CWIG webinar speakers have discussed:

• NIH cloud programs like the Cancer Genomics Cloud, its fellow NCI Cloud Resources, and NIH STRIDES.
• commercial cloud platforms for biomedical data storage and computing.
• pipelines and tools for deep learning and various omics analysis.

Presenters:

• Sharat Israni, Ph.D.

Dr. Israni is the executive director and chief technology officer at UCSF’s Bakar Computational Health Sciences Institute, which is building the UCSF Information Commons.

• Gundolf Schenk, Ph.D.

Dr. Schenk is a principal data scientist working at UCSF’s Bakar Computational Health Sciences Institute, where he applies his skills to integrate clinical notes and automate detection of structure within various modalities of biomedical data.

In partnership with NCI’s Cancer Moonshot^SM Initiative, the Society for Immunotherapy of Cancer (SITC) and the Big Data and Data Sharing Committee are hosting the fourth of nine webinars that make up the 2022 SITC-NCI Computational Immuno-Oncology Webinar Series. Dr. Lillian L. Siu of the Princess Margaret Cancer Centre will be presenting, “Utilizing Correlative Studies for Drug Development: Computational Science in Immuno-Oncology.” The discussion will be moderated by Dr. Dora Hammerl of Erasmus MC Cancer Institute.

The SITC-NCI Computational Immuno-Oncology Webinar Series consists of nine, hour-long courses featuring a moderator and faculty speaker to lead instruction. Topics will cover a host of computational challenges of analyzing and integrating diverse assay data across the spectrum of immuno-oncology. This series is intended for scientists early in their career and/or those who want to remain abreast of the latest technologies. These webinars were created to foster better communication concerning data science technologies and analyses between cancer immunotherapy researchers and clinicians to advance translational immunotherapy research.

Presenters:

• Lillian L. Siu, M.D.

Dr. Siu is a senior scientist at the Princess Margaret Cancer Centre. Here, she works as the director of the Phase I Program, co-director of the Bras and Family Drug Development Program, and the clinical lead for the Tumor Immunotherapy Program.

• Dora Hammerl, Ph.D.

Dr. Hammerl is a postdoctoral researcher at Erasmus MC Cancer Institute.

In this webinar, NCI Program Director Dr. Juli Klemm will give an overview of two trans-NCI programs: Informatics Technology for Cancer Research (ITCR), and the Serological Sciences Network (SeroNet).

The ITCR Program funds investigator-initiated informatics technology development driven by critical needs in cancer research. The presentation will provide an overview of the program’s goals and funding opportunities, as well as highlight some of the supported informatics tools.

SeroNet, established through emergency COVID-19 funding, is leading studies to understand how the immune system responds to SARS-CoV-2 infection and vaccination. The program’s mission, structure, and some key research findings will be discussed.

The Infectious Agents and Cancer Epidemiology Research webinar series is designed to highlight emerging and cutting-edge research related to infection-associated cancers, share scientific knowledge about technologies and methods that may enhance and facilitate infection-associated cancer epidemiology research, and foster cross-disciplinary discussions on infectious agents and cancer epidemiology.

Presenter:

Dr. Juli Klemm is an NCI program director in the Center for Strategic Scientific Initiatives (CSSI) and directs the NCI Informatics Technology for Cancer Research Program supporting open source, investigator-initiated informatics technology development. In addition, Dr. Klemm coordinates the trans-NCI Advisory Committee to CSSI and has been closely involved in organizing SeroNet in support of NCI’s response to the COVID-19 pandemic.